CD14 and ischemic stroke: Specifically, clinical studies in ischaemic stroke and ICH have reported an expansion of classical (CD14+CD16−) and intermediate (CD14+CD16+) populations at the expense of non-classical monocytes (CD14loCD16+) [15, 168].